Streetbeat News

Revenues

LOCL

Local Bounti Corp (LOCL) has provided its FY24 sales guidance, projecting revenues of $50M-$60M, which is below the estimated $61.7M. This forecast is based on production from its operational facilities in Georgia, California, and Montana, with additional contributions from its Texas and Washington facilities as they ramp up.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:06 pm

JBI

Janus International (JBI) has reiterated its FY24 revenue guidance, projecting revenues between $1.092 billion and $1.125 billion, indicating a 4.0% increase from 2023. Adjusted EBITDA is expected to range from $286 million to $310 million, marking a 4.3% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 12:02 pm

JAMF

Analysts have diverse opinions on Jamf Holding (NASDAQ:JAMF), with recent ratings ranging from bullish to bearish. Over the last three months, 10 analysts provided evaluations, showing a shift towards more bullish ratings in the last 30 days. The 12-month price target for JAMF has increased to an average of $22.3, reflecting an 8.25% rise from the previous target of $20.60. Jamf Holding, a leader in Apple Enterprise Management, has shown solid revenue growth of 15.59% as of December 31, 2023, but faces challenges with a net margin of -11.56% and an ROA of -1.11%. Despite these challenges, its ROE of -2.46% surpasses industry standards, and it maintains a low debt-to-equity ratio of 0.51.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 12:01 pm

CXXIF

C21 Investments Inc. reported a slight year-over-year increase in Q4 same-store sales, despite a 12% decline in Nevada sales. The company's FY 2023 financials show a revenue decrease of 2% to $28.3 million, with a net loss of $2.5 million, contrasting with a net income in 2023. Gross profit and margin also declined. The company announced the closing of a CA$4 million convertible debenture offering to fund the acquisition of Deep Roots Harvest, Inc.'s assets, including a dispensary in Southern Reno. This move is part of C21's strategy to expand its retail footprint in Nevada. Additionally, Viridian Capital Advisors anticipates increased M&A activity in the cannabis sector due to regulatory changes.

Portfolio Pulse from Jelena Martinovic

May 09, 2024 | 12:01 pm

BLBD

Blue Bird (NASDAQ:BLBD) has received updated analyst ratings, with a unanimous bullish outlook from 4 analysts. The average 12-month price target is now $45.00, up from $39.50, indicating a 13.92% increase. Recent actions include price target raises by analysts from Needham and Roth MKM, reflecting positive sentiment towards Blue Bird's financial performance and market position. The company has shown impressive revenue growth, net margin, ROE, and ROA, although its debt-to-equity ratio suggests financial challenges.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 12:01 pm

MIRM

Analyst ratings for Mirum Pharmaceuticals (NASDAQ:MIRM) show a mix of bullish and somewhat bullish perspectives with no bearish views in the last three months. The average 12-month price target is $52.6, slightly down from $53.29. Mirum Pharmaceuticals, a biopharmaceutical company, has shown significant revenue growth and strong financial performance, with a focus on developing treatments for rare diseases. Analysts' actions range from maintaining to raising and lowering their price targets and ratings, reflecting their response to the company's performance and market conditions.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 12:01 pm

GENI

Genius Sports (NYSE:GENI) has been evaluated by 9 analysts over the last three months, showing a diverse range of opinions. The average 12-month price target is $8.83, with a high of $10.00 and a low of $7.50, marking an 11.7% decrease in the average price target. Analysts from firms like Needham, Goldman Sachs, and B. Riley Securities have maintained or announced buy ratings, with price targets ranging from $7.50 to $10.00. Genius Sports, a B2B provider in sports and betting technology, has shown a revenue growth of 20.73% as of December 31, 2023, but struggles with profitability and efficiency metrics such as net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 12:00 pm

PAYO

Analysts have mixed views on Payoneer Global (NASDAQ:PAYO), with 8 evaluations in the last three months showing a range from bullish to bearish. The average 12-month price target is now $7.00, down from $7.50, indicating a 6.67% decrease. Recent actions include ratings adjustments and price target changes by analysts from Needham, Benchmark, Citigroup, Cantor Fitzgerald, and Keefe, Bruyette & Woods. Payoneer's financial performance shows a positive revenue trend with a 22.21% growth rate, a net margin of 12.05%, but lagging ROE and ROA compared to industry averages. The company's debt management is considered prudent with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 12:00 pm

SPSC

SPS Commerce has acquired Traverse Systems for around $29.3M, combining cash and stock. The acquisition is expected to add $600,000 in revenue in Q2 2024 but will negatively impact Adjusted EBITDA by $200,000. For the fiscal year 2024, an additional $2.9M in revenue and a breakeven in Adjusted EBITDA are anticipated. By 2025, the acquisition is projected to contribute $5M in revenue and $1.5M in Adjusted EBITDA.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 11:56 am

WRBY

Warby Parker's shares surged following the announcement of improved Q1 GAAP EPS results and sales exceeding expectations. Additionally, the company has uplifted its net revenue guidance for FY24.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 11:53 am